2006-10-13 09:09:52 · 4 answers · asked by kiel_reid 1 in Science & Mathematics ➔ Medicine
If the action of the protein contributes to cancer development, then yes, blocking the action of that protein would make a good drug target. It is also possible that the inaction of a protein might contribute to cancer development. In any case, finding one protein that is implicated in cancer development is not necessarily the 'magic bullet', since developing cancer requires a lot of things going wrong.
2006-10-14 05:43:32 · answer #1 · answered by Cell culturist 1 · 0⤊ 0⤋
A number of the cancer causing proteins exert their undesired activity by being effectively constantly switched on, in these cases chemists can create a drug which blocks the protein.
An example would be the action of Gleevec which is used to treat CML
2006-10-13 16:26:13 · answer #2 · answered by drcjs_007 3 · 0⤊ 0⤋
All tumor markers are proteins. They are different from one another . Not useful to create a drug.
2006-10-14 02:34:36 · answer #3 · answered by J.SWAMY I ఇ జ స్వామి 7 · 0⤊ 0⤋
They can make antibodies that act against the cancer protein.
Antibodies are more specific and so have less side effects.
The first Monoclonal antibody used for treatment in cancer is Herceptin OR Trastuzumab
2006-10-13 19:11:10 · answer #4 · answered by naike_10021980 2 · 0⤊ 0⤋